OTC Oxytrol Approval In U.S. Highlights European Switch Struggles
This article was originally published in The Pink Sheet Daily
Former McNeil Consumer Pharmaceuticals exec Stephen Mann says FDA’s approval of OTC Oxytrol poses a challenge to the EU, where Rx-to-OTC switches and the self-care movement face major obstacles. More regulators are weighing drug switches for chronic conditions, consultant Susan Coleman says.